Moderna target nearly halved by Morgan Stanley on weak guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
Go back to Moderna target nearly halved by Morgan Stanley on weak guidance
January 17, 2025 5:13 AM EST
Jefferies analyst Daniel Fannon raised the price target on Morgan Stanley (NYSE: MS) to $151.00 (from $144.00) while maintaining a Buy rating.
The analyst comments "Post 4Q24 results, we increase our EPS est's for 2025/2026 by +2% each to $8.30/$9.15 from $8.15/$9.00 previously. Positive revisions reflect the flow-through of... More
January 17, 2025 5:07 AM EST
Evercore ISI analyst Glenn Schorr raised the price target on Morgan Stanley (NYSE: MS) to $150.00 (from $140.00) while maintaining a Outperform rating.
The analyst comments "While we were way above the street and expecting a big print, MSs $2.22 handily topped our $1.91 estimate thanks to strong results in the IB, client balances and flows continue that to grow (~$8trn client assets and ~5% organic growth), the returns are high (20% in 4Q/19% for the year), theres a lot of excess... More
